Royce & Associates’s Codexis CDXS Stock Holding History
Bought
Maintained
Sold
Other funds holding CDXS
AIM
NCM
TAM
GGHC
Royce & Associates's CDXS Position: Q2 2022 in Review
Royce & Associates sold out of Codexis (CDXS) in Q2 2022, closing a stake of 19,300 shares — an estimated $398K sold.
Royce & Associates first reported a position in CDXS in Q3 2017 and held it in 5 quarters. The position peaked at $1.8M in Q1 2018. 168 funds tracked by Wall St. Rank hold CDXS as of Q2 2022.
- Royce & Associates reported no remaining Codexis position as of Q2 2022 after selling out during the quarter.
- Royce & Associates sold 19,300 Codexis shares in Q2 2022, an estimated $398K.
- Royce & Associates first reported a position in Codexis in Q3 2017 and held it in 5 quarters.
- Royce & Associates's Codexis position peaked at $1.8M in Q1 2018.
- 168 funds tracked by Wall St. Rank held Codexis as of Q2 2022.
Based on Royce & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.